216 Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study
Titel:
216 Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study
Auteur:
Fill, C. Finelli, C. Gobbi, M. Martinelli, G. Iacobucci, I. Ottaviani, E. Cocco, L. Matilde, F. Candoni, A. Simeone, E. Miglino, M. Lauria, F. Bocchia, M. Defina, M. Clissa, C. Lanza, F. Spedini, P. Skert, C. Bergonzi, C. Malagola, M. Peli, A. Turra, A. Cattina, F. Colombi, C. Russo, D.